Home / Resource Library / Deepening of Response after Completing Rituximab-Containing Primary Therapy in Patients with Waldenstrom Macroglobulinemia

Deepening of Response after Completing Rituximab-Containing Primary Therapy in Patients with Waldenstrom Macroglobulinemia

Study of response from rituximab containing therapies in patients with Waldenstrom Macroglobulinemia.